Search - tctmd.com

Displaying 1 - 20 of 26

Sort: Relevancy | Date

News Daily News

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Michael O'Riordan

October 27, 2020

News Conference News TCT 2020

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

L.A. McKeown

October 26, 2020

News Conference News TCT 2020

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Shelley Wood

October 14, 2020

News Conference News TCT 2020

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Caitlin E. Cox

October 14, 2020

News Conference News TCT 2020

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Michael O'Riordan

October 14, 2020

Presentation TCT 2020

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction

Presenter: Gregg Stone

October 14, 2020

News Conference News TCT 2020

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

L.A. McKeown

October 14, 2020

Presentation TCT 2020

TCT 521: Biventricular Impella Support in a Patient With Cardiogenic Shock and Heparin-Induced Thrombocytopenia and Thrombosis

Presenter: Joshua Aymond

October 14, 2020

News Daily News

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Michael O'Riordan

October 02, 2020

News Daily News

Study Affirms Thrombotic Risk in COVID-19

Todd Neale

October 01, 2020

News Conference News ESC 2020

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

Caitlin E. Cox

September 04, 2020

News Daily News

COVID-19: TCTMD’s Daily Dispatch for September

Todd Neale

September 01, 2020

News Daily News

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Michael O'Riordan

August 28, 2020

News Daily News

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

Caitlin E. Cox

July 22, 2020

News Daily News

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Yael L. Maxwell

July 21, 2020

News Daily News

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

Michael O'Riordan

June 08, 2020

News Daily News

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Yael L. Maxwell

May 12, 2020

News Daily News

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

Michael O'Riordan

April 29, 2020

News Daily News

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Michael O'Riordan

April 22, 2020

News Conference News ACC 2020

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

L.A. McKeown

April 01, 2020

Advertisement

Thrombotic Events Frequent Among COVID-19 Patients in ICUs

Microclots Seen on OCT and Autopsy Can Inform COVID-19 Diagnostics, Care

Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate

Valve Disease Plus COVID-19 Often a Lethal Combination, Registry Shows

Interventionalists, Including PERTs, Grapple With VTE Risks of COVID-19

Individual Patient Data Pooled Analysis of Randomized Trials of Bivalirudin Versus Heparin in Acute Myocardial Infarction

No Reperfusion Benefit From Crushed Prasugrel Prior to PCI: COMPARE CRUSH

TCT 521: Biventricular Impella Support in a Patient With Cardiogenic Shock and Heparin-Induced Thrombocytopenia and Thrombosis

Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care

Study Affirms Thrombotic Risk in COVID-19

Chinese Data Back Anticoagulants to Prevent COVID-19 Thromboembolism

COVID-19: TCTMD’s Daily Dispatch for September

Systemic Anticoagulation Linked to Lower Mortality in Hospitalized COVID-19

Don’t Mistake Microthrombi for Myocarditis in COVID-19 STEMI, Case Report Warns

In COVID-19 Pulmonary Embolism, Nontraditional Risk Factors Dominate

Possible Antithrombotic and Anti-inflammatory Therapies for COVID-19

New AHA Guidance on Hospital VTE Stresses Risk Assessment, Standardization

Pulmonary Embolism in COVID-19 Patients: New Numbers, Little Consensus

How COVID-19 Promotes Thrombosis, Posing Problems for Drug-Drug Interactions

Caravaggio Backs Apixaban for Prevention of VTE Recurrence in Cancer Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content